| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ruxolitinib phosphate | FAERS: 45 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 14 | US FAERS | |
| 3 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 6 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 6 | OFFSIDES US FAERS | |
| 5 | Decitabine | FAERS: 3 | US FAERS | |
| 6 | Deferasirox | FAERS: 2 | US FAERS | |
| 7 | Hydroxyurea | FAERS: 2 | US FAERS | |
| 8 | Prednisolone | FAERS: 2 | US FAERS | |
| 9 | Terbinafine | FAERS: 2 | OFFSIDES US FAERS | |
| 10 | pimecrolimus | FAERS: 2 | OFFSIDES US FAERS | |
| 11 | ponatinib | FAERS: 2 | US FAERS | |
| 12 | Azathioprine | FAERS: 1 | US FAERS | |
| 13 | Bortezomib | FAERS: 1 | US FAERS | |
| 14 | INCB018424 | FAERS: 1 | US FAERS | |
| 15 | Lenalidomide | FAERS: 1 | US FAERS | |
| 16 | Melphalan | FAERS: 1 | US FAERS | |
| 17 | Mesalamine | FAERS: 1 | US FAERS | |
| 18 | Risperidone | FAERS: 1 | US FAERS | |
| 19 | Sorafenib | FAERS: 1 | US FAERS | |
| 20 | venetoclax | FAERS: 1 | US FAERS | |
| 21 | Allopurinol | OFFSIDES | ||
| 22 | Aminocaproic Acid | OFFSIDES | ||
| 23 | Cefdinir | OFFSIDES | ||
| 24 | Cytarabine | OFFSIDES | ||
| 25 | Danazol | OFFSIDES | ||
| 26 | Etoposide | OFFSIDES | ||
| 27 | Galactose | OFFSIDES | ||
| 28 | Meprednisone | OFFSIDES | ||
| 29 | Mercaptopurine | OFFSIDES | ||
| 30 | Methotrimeprazine | OFFSIDES | ||
| 31 | Methylprednisolone Hemisuccinate | OFFSIDES | ||
| 32 | Pentamidine | OFFSIDES | ||
| 33 | Tranexamic Acid | OFFSIDES | ||
| 34 | difluprednate | OFFSIDES | ||
| 35 | fludarabine | OFFSIDES | ||
| 36 | zopiclone | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.